Abstract
Our understanding of the pathogenesis of hyperlipoproteinemia stems from knowledge of the synthesis, secretion and metabolism of plasma lipoproteins and the regulation of These processes. Application of this knowledge in recent years has provided an explanation of several secondary hyperlipoproteinemias in terms of altered regulation of fat transport. This paper will review current knowledge of fat transport in lipoproteins and the increasing evidence that all major lipoprotein classes are involved in this process. The pathogenesis of certain secondary hyperlipoproteinemias will be discussed in the context of this review. Finally, a speculative assessment of the pathogenesis of the primary hyperlipoproteinemias will be attempted with particular reference to possible mechanisms of defective catabolism.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Havel, R.J. New Engl. J. Med. In press.
Werner, Bengt. Acta Chir. Scand. 132: 63 (1966)
Scherstén, T., S. Nilsson, E. Cahlin, M. Filipson and G. Brodin-Perssono Europ. J. Clin. Invest. I: 242 (1971)
Hamilton, R.L. This symposium.
Gotto, A.M., R.I. Levy, K. John, and D. S. Fredrickson. New Engl. J. Med. 284: 813 (1971)
Glomset, J.A., K.R. Norum, and W. King. J. Clin. Invest. 49: 1827 (1970)
Havel, R.J., V.G. Shore, B. Shore, and D. M. Bier. Circ. Res. 27: 595 (1970)
LaRosa, J.C., R.I. Levy, P. Herbert, S.E. Lux, and D. S. Fredrickson. Biochem. Biophys. Res. Comm. 41: 57 (1970)
Havel, R.J., M.L. Kashyap, and J. P. Kane. Circulation 42: 11–9 (1971)
Bilheimer, D., S. Eisenberg, and R. I. Levy. J. Clin. Invest. 50: 8a (1971)
Shore, B. and V. Shore. Biochem. 8: 4510 (1969)
Nestel, P.J., R. J. Havel and A. Bezmano J. Clin. Invest. 42: 1313 (1963).
Redgrave, T.G. J. Clin. Invest. 49: 465 (1970)
Bergman, E.N., R. J. Havel, B. M. Wolfe, and T. BfAhmer. J. Clin. Invest. 50: 1831 (1971)
Sata, T. and R. J. Havel. Unpublished observations.
Gitlin, D., D.G. Cornwell, D. Nakasato, J.L. Oncley, W.L. Hughes, Jr., and C. A. Janeway. J. Clin. Invest. 37: 172 (1958)
Havel, R.J. Atherosclerosis, Proc. II Internat. Symp. (Ed.) R.J. Jones, Springer Verlag, New York (1970) p. 210
Havel, R.J., J.P. Kane, E.O. Balasse, N. Segel, and L. V. Basso. J. Clin. Invest. 49: 2017 (1970)
Basso, L.V. and R. J. Havel. J. Clin. Invest. 49: 537 (1970).
Balasse, E.O., D. M. Bier, and R. J. Havel. Diabetologia 6: 618 (1970)
Havel, R.J., in Muscle Metabolism During Exercise. (Eds.) B. Pernow and B. Saltin, Plenum Press, New York (1971) p. 315.
Havel, R.J. J. Clin. Invest. 36: 855 (1957)
Wolfe, B.M., R.J. Havel, E.B. Marliss, J.P. Kane, and J. Seymour. J. Clin. Invest. 49: 104a (1970)
Mayes, P.A. and J.M. Felts. Nature 215: 716 (1967)
Barter, P.J. and P.J. Nestel. Metabolism. In press.
Sandhofer, F., K. Bolzano, S. Siler. and H. Braunsteiner. Klin. Wschr. 47: 1086 (1969)
Havel, R.J., E.O. Balasse, H.E. Williams, J.P. Kane, and N. Segel. Trans. Assoc. Amer. Physicians 82: 305 (1969)
Farber, E. Adv. Lipid Res. 5: 119 (1967)
Havel, R.J. Calif. Med. 115: 23 (1971)
Marsh, J.B. and D.L. Draekin. Metabolism 9: 946 (1960)
Baxter, J.H., H.C. Goodman, and R.J. Havel. J. Clin. Invest. 39: 455 (1960)
Bagdade, J.D., D. Porte, Jr., and E. L. Bierman. New Engl. J. Med. 276: 427 (1967)
Havel, R.J. Adv. Int. Med. 15: 117 (1969)
Porte, D., Jr., D.D. O’Hara, and R.H. Williams. Metabolism 15: 107 (1966)
Glueck, C.J., A.P. Kaplan, R.I. Levy, H. Greten, H. Gralnick, and D.S. Fredrickson. Ann. Int. Med. 71: 1051 (1969).
Fielding, C.J. Personal communication
Whayne, T.F. and J.M. Felts. Circulation 62: 111–6 (1970)
Shafrir, E. J. Clin. Invest. 37: 1775 (1958)
Morell, A.G., G. Gregoriadis, I.H. Scheinberg, J. Hickman and G. Ashwell. J. Biol. Chem. 246: 1461 (1971)
Margolis, S. and R.G. Langdon, J. Biol. Chem. 241: 469 (1966)
Fredrickson, D.S., R.I. Levy, and R.S. Lees. New Engl. J. Med. 276: 32 (1967)
Fredrickson, D., K. Ono, and L.L. Davis. J. Lipid Res. 4: 24 (1963)
Sandhofer, F., S. Sailer, M. Herbst, and H. Braunsteiner. Dtsch. Med. Wschr. 90: 755 (1965)
Boberg, J. Acta Univ. Upsaliensis. 105: 1 (1971)
Persson, B., P. Bjbrntorp, and B. Hood. Metabolism 15: 730 (1966).
Reaven, G.M., R.L. Lerner, M. P. Stern, and J.W. Farquhar. J. Clin. Invest. 46: 1756 (1967)
Quarfordt, S., R.I. Levy, and D.S. Fredrickson. J. Clin. Invest. 50: 75 (1971)
Hazzard, W.R. and E. L. Bierman. Clin. Res. 19: 476 (1971)
Langer, T., W. Strober and R.I. Levy. J. Clin. Invest. 48: 49a (1969)
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1972 Springer Science+Business Media New York
About this chapter
Cite this chapter
Havel, R.J. (1972). Mechanisms of Hyperlipoproteinemia. In: Holmes, W.L., Paoletti, R., Kritchevsky, D. (eds) Pharmacological Control of Lipid Metabolism. Advances in Experimental Medicine and Biology, vol 26. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-7547-0_4
Download citation
DOI: https://doi.org/10.1007/978-1-4684-7547-0_4
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-7549-4
Online ISBN: 978-1-4684-7547-0
eBook Packages: Springer Book Archive